Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -0.401% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) CCOc1ccc(N(CC(=O)NCCOc2ccc(C)cc2)S(=O)(=O)c2ccccc2)cc1
b) COc1cc(/C(C)=N/NC(=O)c2cccc(S(=O)(=O)N3CCCC3)c2)cc(OC)c1OC
c) Cc1ccc(S(=O)(=O)Nc2ccc(N3CCCCC3)cc2)cc1
d) CCC1SC2=NCCN2C1(O)c1ccc(Cl)cc1
e) O=C(Cn1c(=O)c2sccc2n(Cc2ccc([N+](=O)[O-])cc2)c1=O)NCCc1ccccc1
Answer: c. Cc1ccc(S(=O)(=O)Nc2ccc(N3CCCCC3)cc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)Nc2ccc(N3CCCCC3)cc2)cc1
Cc1ccc(S(=O)(=O)Nc2ccc(N3CCCCC3)cc2)cc1
4-methyl-N-(4-piperidin-1-ylphenyl)benzenesulfonamide